trending Market Intelligence /marketintelligence/en/news-insights/trending/d5FZ_MXUY1yQ-GId56QZ5g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Interpace to raise $4M in direct offering, private placement

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Interpace to raise $4M in direct offering, private placement

Interpace Diagnostics Group Inc. plans to raise about $4 million in a registered direct offering of common shares and a concurrent private placement of warrants.

The company will sell 855,000 common shares and warrants to purchase an equivalent number of shares to three institutional investors. The combined purchase price for one registered share of common stock and one warrant is $4.69.

The warrants have an exercise price of $4.69 per share. The warrants will be immediately exercisable after the closing of the private placement and will expire after the five years.

Gross proceeds to the company from the registered direct offering and concurrent private placement are estimated to be about $4.0 million before deducting the placement agent's fee and other estimated offering expenses. Net proceeds will be used for working capital, repayment of debt and general corporate purposes.

The offering and placement are expected to close on or about Jan. 25, subject to customary closing conditions.

Maxim Group LLC is acting as the exclusive placement agent for the offering.